In current times, the blend of Ivermectin, Azithromycin, and Hydroxychloroquine has captured significant interest as potential treatments for different health ailments. From their established utilizations in parasitic and bacterial infections to their investigation in managing viral illnesses such as COVID-19, these medications have become subjects